» Authors » Cecile D Lahiri

Cecile D Lahiri

Explore the profile of Cecile D Lahiri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 313
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu K, Zhang X, Asam K, Quach B, Page G, Konkle-Parker D, et al.
Clin Transl Med . 2025 Mar; 15(3):e70267. PMID: 40070009
Background: The HIV-1 reservoir in CD4+ T cells (HR) pose a major challenge to curing HIV, with many of its mechanisms still unclear. HIV-1 DNA integration and immune responses may...
2.
Yu M, Gerig L, Mehta C, Musonge-Effoe J, Alvarez J, Ofotokun I, et al.
Clin Infect Dis . 2025 Feb; PMID: 39899358
Background: The impact of integrase strand-transfer inhibitors (INSTIs) on steatotic liver disease in women with HIV (WWH) is unknown. Methods: Using data collected in the Women's Interagency HIV Study from...
3.
Vatsa N, Rahbar A, Kauser T, Kirksey A, Gold D, Jain V, et al.
JACC Adv . 2025 Jan; 4(2):101572. PMID: 39832389
Background: HIV induced endothelial dysfunction (ED) contributes to cardiovascular disease (CVD) in women with HIV (WWH). Although psychosocial stress has been implicated in the development of CVD in HIV, its...
4.
Chichetto N, Canidate S, Gebru N, McNeely K, Ding D, Hanna D, et al.
Drug Alcohol Depend . 2024 Dec; 266():112523. PMID: 39662355
Background: Heavy drinking, smoking, and depression are common among men who have sex with men (MSM). The association of co-occurring longitudinal patterns of these conditions and mortality among MSM were...
5.
Tiendrebeogo T, Malateste K, Poda A, Minga A, Lahiri C, Ezechi O, et al.
J Int AIDS Soc . 2024 Nov; 27(12):e26371. PMID: 39604062
Introduction: Adverse metabolic effects related to dolutegravir (DTG) are increasingly reported as countries are adopting DTG-based regimens as first-line antiretroviral therapy (ART), but there is limited data from sub-Saharan Africa....
6.
Alvarez J, Yang C, Ojuri V, Buckley K, Bedi B, Musonge-Effoe J, et al.
Curr HIV/AIDS Rep . 2024 Nov; 22(1):3. PMID: 39570329
Purpose Of Review: As advances in antiretroviral therapy for people with HIV (PWH) have prolonged lifespans, prevalence of aging and obesity related metabolic disorders have increased. The purpose of this...
7.
Abelman R, Ma Y, Mehta C, Yang Q, Xia F, Brock J, et al.
Clin Infect Dis . 2024 Nov; PMID: 39495675
Background: Integrase strand transfer inhibitors (INSTIs) and the menopausal transition have separately been associated with body composition changes in women with HIV (WWH), but their interaction is unknown. Methods: From...
8.
Lahiri C, Mehta C, Yang Q, Maramba T, Musonge-Effoe J, Yang C, et al.
Clin Infect Dis . 2024 Sep; PMID: 39324701
Background: Sex-specific, long-term, body weight change in persons with HIV (PWH) following switch to regimens containing integrase strand-transfer inhibitors (INSTIs) is unknown. Methods: We compared PWH enrolled in the MACS/WIHS...
9.
Aouizerat B, Garcia J, Domingues C, Xu K, Quach B, Page G, et al.
J Acquir Immune Defic Syndr . 2024 Sep; 97(2):156-164. PMID: 39250649
Background: Cocaine-one of the most frequently abused illicit drugs among persons living with HIV [people living with HIV (PLWH)]-slows the decline of viral production after antiretroviral therapy and is associated...
10.
Aldredge A, Mehta C, Lahiri C, Schneider M, Alcaide M, Anastos K, et al.
AIDS . 2024 Aug; 38(13):1829-1838. PMID: 39110550
Objective: Investigate the outcomes of women with HIV (WWH) with low-level viremia (LLV). Design: The prevalence of LLV and potential clinical sequelae, such as virologic failure and non-AIDS comorbidity (NACM)...